[Medicine] key words of this week's local New Deal: consistency evaluation purchase, basic medicine supplement, limited infusion, online prescription medicine

Key word 1: on January 10, the drug procurement management platform of Xinjiang Medical Institutions issued the notice on ensuring the supply of drugs through the consistency evaluation of quality and efficacy of generic drugs (nwyzf [2018] No.7), For the drugs that have passed the consistency evaluation of quality and efficacy of generic drugs (including those deemed to have passed the consistency evaluation), we will carry out the Declaration on the centralized procurement management platform of drugs in the region, and carry out online procurement as required It is not uncommon to adopt the policy of "direct Internet access" through consistent generic drugs Previously, Liaoning, Shanghai, Jilin and Guangxi have clearly required to carry out direct online purchase of evaluated drugs Anhui, Shandong, Hubei and other provinces require medical institutions at all levels to give priority to purchasing and using These policies guarantee the "patent rights" of 79 evaluated varieties in local procurement Key words 2: supplement of basic drugs on January 7, Zhejiang health and Health Commission publicly solicited opinions of General Office of Zhejiang Provincial People's Government on the implementation of national basic drug system There are four points to be noted in the documents: 1 Priority should be given to the directory of base drugs Public medical institutions at all levels in the province should take the national essential drugs as the first choice for clinical diagnosis and treatment, highlighting the clinical value of essential drugs 2 Basic drugs will not be supplemented in Zhejiang Province After the publication of the new edition of the national essential drug catalogue, our province will no longer formulate the supplementary catalogue, and the drugs in the list of commonly used drugs outside the catalogue of essential drugs of basic medical and health institutions in Zhejiang Province (zwf [2014] No 90) will no longer be managed as essential drugs 3 Up regulate the proportion of base drugs The purchase amount of basic drugs of the second class B hospitals and primary medical institutions shall not be less than 40% of the total purchase amount of drugs of the medical institutions, not less than 30% of the second class A hospitals, not less than 25% of the third class B hospitals, not less than 20% of the third class A hospitals, not less than 20% of the obstetrics and Gynecology hospitals, not less than 20% of the children's hospitals, not less than 15% of the tumor hospitals and not less than 25% of the stomatological hospitals, Each member unit of county medical community shall control the proportion of leading hospitals 4 The hospital should pay back in time The drug manufacturing enterprise shall earnestly perform the contract, and the medical insurance agency shall timely prepay and allocate medical insurance funds to the medical institution in accordance with the relevant provisions, and the medical institution shall timely settle the payment for goods in strict accordance with the relevant provisions without delay First, let's talk about the first "list of priority drugs" and the third "proportion of basic drugs" Previous industry figures said that the use of the new version of the list of base drugs only relies on "priority use", but did not specify the dosage, which does not seem to reflect the advantages of the base drugs However, at the beginning of January 2019, Shandong health and Health Commission issued a document requiring that the proportion of basic drugs purchased by basic medical and health institutions in the total amount of drug procurement should be controlled above the original level in principle; Liaoning and Jilin provinces re stipulated the proportion of allocation and use, and Liaoning promised that the national basic drugs catalogue would not be included in the proportion of drugs Now it seems that with the gradual progress of hierarchical diagnosis and treatment, the implementation of the new version of the drug base directory varies from place to place How to reflect the advantages depends on the specific situation of the local area In addition, each province has different regulations on whether to add base drugs or abolish the original local base drug catalogue Zhejiang Province will no longer supplement base drugs, and the drugs in the province's non base drug list will be converted to "non base drug" management; Hubei Province will abolish the drug list of non base drug list at the beginning of the year, and convert it to "non base drug" management, and after the original "non base drug list" is included in the new base drug list, its online price will be adjusted to the lowest price in the country; Hunan and Gansu provinces will retain the original "national basic drug place" The original local supplementary catalogue will be abolished in Qinghai, Jilin, Chongqing, Shandong and Fujian Up to now, more than 10 regions have not made specific provisions on the handling of the original local supplementary catalogue Key word 3: Anti Japanese order??? On January 6, the first hospital of Jilin University, a famous third-class hospital in Jilin Province, cancelled the infusion of adult general outpatient service It is said that at present, 11 hospitals at the provincial, municipal and county level in the province have cancelled the adult general outpatient infusion When it comes to the "anti drug restriction order", 12 provinces and cities, including Guangxi, Hainan, Liaoning and Hunan, have issued documents to restrict and cancel outpatient infusion First, to prevent the deterioration of antibiotic abuse, second, to reduce the occurrence of adverse medical events, third, to implement the hierarchical diagnosis and treatment system, and to save the medical resources of the tertiary hospitals Accordingly, the cancellation of "outpatient infusion" has a direct impact on the production, sales and profits of injection production enterprises Based on this, some enterprises have turned the spotlight and carried out transformation and upgrading For example, China Resources Shuanghe and Kelun pharmaceutical have already laid out general medicine market and OTC market Key words 4: oseltamivir and online prescription drugs recently, Guangdong health and Health Commission issued a document requesting medical institutions to purchase sufficient neuraminidase inhibitors (children use granules) such as oseltamivir phosphate in time for clinical normal anti influenza treatment As we all know, when the annual influenza virus hits, the supply of oseltamivir will be tight, and even a box of difficult conditions will appear But recently, it is reported on the Internet that patients can buy oseltamivir online, which is cheaper than physical pharmacies That is to say, as a prescription drug, oseltamivir can be purchased by electronic prescription, so its production and sales will also leap Of course, once online prescription drugs are released, it's not only oseltamivir that is on fire, but other commonly used drugs Recently, the measures for the supervision and administration of drug online sales (Draft for examination) has been circulated in the industry, which stipulates the main body, scope and relevant obligations of online sales of prescription drugs The first is that the drug network seller should be the holder of the drug listing license or the drug handling enterprise; the second is that the holder of the drug should hold the approval number of the drug; the third is that the drug manufacturing enterprise entrusted with processing and manufacturing can accept the entrustment to sell the drug of the holder; the fourth is that the scope of drug network sales should not exceed the business scope of the enterprise; Fifthly, if the drug network seller is the holder and the drug wholesale enterprise, it is not allowed to sell drugs to individual consumers Internet plus there are both advantages and disadvantages The online prescription drug supervision is also a difficult point Key words 5: API On January 8, the health and Health Commission of Inner Mongolia issued a notice that from May 1, 2018 to December 31, 2018, due to the rise of raw materials, production line transformation, environmental pollution and other reasons, many drugs stopped production 43 drug manufacturers (agents) such as Anhui golden sun Biochemical Pharmaceutical Co., Ltd and Bayer medical and health Co., Ltd Guangzhou branch actively applied for the cancellation of 108 drug online qualification , and submit the letter of commitment of national unified non supply Since then, it is not difficult to find out that the topic that can not be bypassed is the rising price and insufficient supply of APIs Of course, it's normal for some drugs to be eliminated, but some drugs in short supply and low-cost drugs will be stopped or disappear due to human factors, which will surely be rectified Information source: Pharmaceutical intelligence news, cypress blue, health and Information Bureau, pharmacy manager, pharmaceutical intelligence elite club and other statements: this point of view only represents the author, not the position of pharmaceutical intelligence network, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.